Drug Profile
DP VPA
Alternative Names: DP-VPA; SPD 421Latest Information Update: 28 Dec 2017
Price :
$50
*
At a glance
- Originator D-Pharm
- Class Antiepileptic drugs; Neuroprotectants; Pentanoic acids
- Mechanism of Action GABA uptake inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase II Epilepsy
- No development reported Bipolar disorders; Migraine
Most Recent Events
- 28 Dec 2017 No recent reports of development identified for phase-I development in Bipolar-disorders in Israel (PO, Tablet)
- 28 Dec 2017 No recent reports of development identified for phase-I development in Migraine in Israel (PO, Tablet)
- 16 Dec 2015 Phase-II development is ongoing for Epilepsy and phase I development is ongoing for Migraine and Bipolar disorders, in Israel